gastroenteritis With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu Premium Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases. Mobidiag Secures €25M Loan to Build Test Menu The four-year loan will be used to develop molecular diagnostic assays for the firm's two test systems, Amplidiag and Novodiag. Meridian Biosciences Expects MDx Business Rejuvenation With GenePOC Acquisition Premium Cincinnati, Ohio-based Meridian will acquire Quebec City-based GenePOC for $120 million, and hopes to quickly convert customers to a PCR-based instrument. Study of Luminex GI Panel in Children Reveals Salmonella Detection Issue Premium Luminex has since fixed the problem with a software update but a similar issue with non-specific amplification has also affected two targets on BioFire's GI panel. Becton Dickinson Gets FDA Clearance for Enteric Viral Panel The enteric panel detects the viral cause of infectious diarrhea symptoms including norovirus, rotavirus, adenovirus, human astrovirus, and sapovirus. Dec 17, 2018 Mobidiag, Autobio Diagnostics to Form Joint Venture in China Oct 1, 2018 Applied Biocode MDx System, GI Pathogen Panel Get FDA 510(k) Clearance May 30, 2017 MobiDiag Extends Distribution Agreement With PerkinElmer Apr 20, 2017 Applied Biocode to Submit Gastrointestinal Pathogen Panel to FDA in Bid to Displace Luminex Premium Sep 24, 2015 BD Max Enteric Parasite Panel Gets FDA OK Jun 8, 2015 Study Shows Impact of BD Max Enteric Bacterial Panel on Lab Workflow Premium Mar 17, 2015 BD Max Enteric Bacterial Panel Superior to Conventional Methods in Large Evaluation Premium Dec 1, 2014 Cepheid Gets FDA Clearance for Xpert Norovirus Assay Nov 18, 2014 Australian MDx Firm Genetic Signatures Eyes IPO for up to A$15M Sep 29, 2014 FDA Clears Three Additional Targets for Luminex Gastrointestinal Pathogen Panel Sep 23, 2014 Mobidiag Bacterial Gastroenteritis Assay Gets CE Mark May 7, 2014 FDA Clears BD Max Enteric Bacterial Panel Jul 18, 2013 BioFire Diagnostics Nets $1.4M from NIAID to Move FilmArray GI Panel through FDA Approval Process Premium Jul 11, 2013 Theradiag Distributing Luminex Assays in France Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.